全球癌症恶病质市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

预计到 2032 年，全球癌症恶病质市场的市场规模将从 2023 年的 28.4 亿美元达到近 45 亿美元，2024-2032 年研究期间复合年增长率为 5.22%。

癌症恶病质是一种复杂的代谢综合征，其特征是癌症患者严重体重减轻、肌肉萎缩和食慾下降。与单纯的营养不良不同，恶病质是由潜在的癌症相关因素引起的，涉及全身性发炎、代谢改变和蛋白质分解增加。这种情况会严重影响患者的生活品质，使治疗方案复杂化，并导致预后不良。此症候群的病理生理学涉及肿瘤衍生因子与宿主代谢过程之间的相互作用，导致体重和力量逐渐丧失。有效管理这种综合征对于改善患者预后和提高癌症治疗效果至关重要。治疗通常包括营养支持、抗发炎药物和针对潜在疾病机制的介入措施。解决恶病质对于全面的癌症护理和改善受影响患者的整体健康至关重要。

市场动态

全球癌症盛行率不断上升，这反过来又推动了对恶病质等相关併发症的有效管理策略的需求。随着癌症发生率的上升，对治疗恶病质的疗法的需求变得更加迫切，从而创造了巨大的癌症恶病质市场潜力。另一个驱动因素是人们越来越认识到癌症恶病质是一种需要专门治疗的独特而严重的疾病。医疗保健专业人员和患者对恶病质对癌症结果影响的认识不断提高，这推动了对有效治疗方案的需求。这种认识导致更多的研究和开发工作集中在了解恶病质的潜在机制和开发有针对性的治疗方法。针对恶病质涉及的代谢和发炎途径的新疗法的开发提供了巨大的机会。药物开发和营养干预的创新为新的治疗选择打开了大门，可以改善患者的治疗结果。此外，个人化医疗的进步允许根据个别患者的情况采取更量身定制的方法来管理恶病质。製药公司、研究机构和临床组织之间的合作推动了成长。这些合作关係对于进行临床试验、推进研究以及将新疗法推向市场至关重要。然而，有限的治疗选择和高昂的成本可能会阻碍癌症恶病质市场的成长。有效疗法的稀缺性以及与开发和获得恶病质治疗相关的经济负担可能会限制市场扩张并影响患者获得护理的机会。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对癌症恶病质全球市场的每个细分市场进行了包容性评估。癌症恶病质产业的成长和趋势为本研究提供了整体方法。

市场区隔

癌症恶病质市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

透过治疗学

• 黄体素
• 皮质类固醇
• 联合疗法
• 其他的

按作用机制

• 食慾刺激器
• 减肥稳定剂
• 其他的

按配销通路

• 医院商店
• 零售药局
• 网路药局

区域分析

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲癌症恶病质市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。癌症恶病质市场的主要参与者包括 Aeterna Zentaris Inc.、Alder BioPharmaceuticals Inc.、Aphios Corporation、Eli Lilly And Company、GlxInc.、Helsinn Group、Merck & Co. Inc.、Novartis AG、Bristol-Myers Squibb Company、XBiotech公司。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：癌症恶病质 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 治疗方法的市场吸引力分析
  • 依作用机制进行市场吸引力分析
  • 按配销通路分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球癌症恶病质市场分析：依治疗方法

• 治疗概述
• 治疗的历史和预测数据分析
• 黄体素
• 皮质类固醇
• 联合疗法
• 其他的

第 6 章：全球癌症恶病质市场分析：按作用机制

• 按作用机制概述
• 依作用机制进行历史与预测资料分析
• 食慾刺激器
• 减肥稳定剂
• 其他的

第 7 章：全球癌症恶病质市场分析：按分销管道

• 配销通路概览
• 按配销通路进行历史和预测资料分析
• 医院商店
• 零售药局
• 网路药局

第 8 章：全球癌症恶病质市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：癌症 Cachexia 公司的竞争格局

• 癌症恶病质市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Aeterna Zentaris Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Alder BioPharmaceuticals Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Aphios Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• Eli Lilly And Company
• 公司概况
• 公司收入
• 产品
• 最新动态
• GlxInc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Helsinn Group
• 公司概况
• 公司收入
• 产品
• 最新动态
• Merck & Co. Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Novartis AG
• 公司概况
• 公司收入
• 产品
• 最新动态
• Bristol-Myers Squibb Company
• 公司概况
• 公司收入
• 产品
• 最新动态
• XBiotech Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for Cancer Cachexia Market is presumed to reach the market size of nearly USD 4.5 Billion by 2032 from USD 2.84 Billion in 2023 with a CAGR of 5.22% under the study period 2024-2032.

Cancer cachexia is a complex metabolic syndrome featuring severe weight loss, muscle wasting, and decreased appetite in cancer patients. Unlike simple malnutrition, cachexia is driven by underlying cancer-related factors and involves systemic inflammation, altered metabolism, and increased protein breakdown. This condition significantly impacts a patient's quality of life, complicates treatment regimens, and contributes to poor prognoses. The pathophysiology of this syndrome involves interactions between tumor-derived factors and the host's metabolic processes, leading to the progressive loss of body mass and strength. Effective management of this syndrome is critical for enhancing patient outcomes & enhancing the efficacy of cancer therapies. Treatments often include nutritional support, anti-inflammatory agents, and interventions targeting the underlying disease mechanisms. Addressing cachexia is essential for comprehensive cancer care and improving the overall well-being of affected patients.

MARKET DYNAMICS

The increasing prevalence of cancer globally, which in turn drives demand for effective management strategies for associated complications like cachexia. As the incidence of cancer rises, the need for therapies addressing cachexia becomes more critical, creating significant cancer cachexia market potential. Another driver is the growing recognition of cancer cachexia as a distinct and serious condition requiring specialized treatment. The increased awareness among healthcare professionals & patients about the impact of cachexia on cancer outcomes is fuelling the demand for effective therapeutic options. This awareness is leading to more research and development efforts focused on understanding the underlying mechanisms of cachexia and developing targeted treatments. The development of novel therapies targeting the metabolic and inflammatory pathways involved in cachexia presents substantial opportunities. Innovations in drug development and nutritional interventions open the door to new treatment options that can improve patient outcomes. Additionally, the advancement of personalized medicine allows for more tailored approaches to managing cachexia based on individual patient profiles. Collaborations between pharmaceutical companies, research institutions, and clinical organizations drive growth. These partnerships are essential for conducting clinical trials, advancing research, and bringing new treatments to market. However, limited treatment options and high costs may hinder cancer cachexia market growth. The scarcity of effective therapies and the financial burden associated with developing and accessing cachexia treatments can restrict market expansion and affect patient access to care.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cancer Cachexia. The growth and trends of Cancer Cachexia industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cancer Cachexia market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutics

• Progestogens
• Corticosteroids
• Combination Therapies
• Others

By Mechanism of Action

• Appetite Stimulators
• Weight Loss Stabilizers
• Others

By Distribution Channel

• Hospital Stores
• Retail Pharmacy Stores
• Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cancer Cachexia market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cancer Cachexia market include Aeterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corporation, Eli Lilly And Company, GlxInc., Helsinn Group, Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, XBiotech Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. CANCER CACHEXIA - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Therapeutics
  • 3.7.2 Market Attractiveness Analysis By Mechanism of Action
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER CACHEXIA MARKET ANALYSIS BY THERAPEUTICS

• 5.1. Overview By Therapeutics
• 5.2. Historical and Forecast Data Analysis By Therapeutics
• 5.3. Progestogens Historic and Forecast Sales By Regions
• 5.4. Corticosteroids Historic and Forecast Sales By Regions
• 5.5. Combination Therapies Historic and Forecast Sales By Regions
• 5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL CANCER CACHEXIA MARKET ANALYSIS BY MECHANISM OF ACTION

• 6.1. Overview By Mechanism of Action
• 6.2. Historical and Forecast Data Analysis By Mechanism of Action
• 6.3. Appetite Stimulators Historic and Forecast Sales By Regions
• 6.4. Weight Loss Stabilizers Historic and Forecast Sales By Regions
• 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL CANCER CACHEXIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 7.1. Overview By Distribution Channel
• 7.2. Historical and Forecast Data Analysis By Distribution Channel
• 7.3. Hospital Stores Historic and Forecast Sales By Regions
• 7.4. Retail Pharmacy Stores Historic and Forecast Sales By Regions
• 7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL CANCER CACHEXIA MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER CACHEXIA COMPANIES

• 9.1. Cancer Cachexia Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF CANCER CACHEXIA INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Aeterna Zentaris Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Alder BioPharmaceuticals Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Aphios Corporation
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Eli Lilly And Company
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. GlxInc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Helsinn Group
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Merck & Co. Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Novartis AG
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Bristol-Myers Squibb Company
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. XBiotech Inc
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Therapeutics (USD MN)
• Progestogens Market Sales By Geography (USD MN)
• Corticosteroids Market Sales By Geography (USD MN)
• Combination Therapies Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By Mechanism of Action (USD MN)
• Appetite Stimulators Market Sales By Geography (USD MN)
• Weight Loss Stabilizers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital Stores Market Sales By Geography (USD MN)
• Retail Pharmacy Stores Market Sales By Geography (USD MN)
• Online Pharmacies Market Sales By Geography (USD MN)
• Global Cancer Cachexia Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cancer Cachexia Report
• Market Research Process
• Market Research Methodology
• Global Cancer Cachexia Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Therapeutics
• Market Attractiveness Analysis By Mechanism of Action
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Therapeutics (USD MN)
• Progestogens Market Sales By Geography (USD MN)
• Corticosteroids Market Sales By Geography (USD MN)
• Combination Therapies Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By Mechanism of Action (USD MN)
• Appetite Stimulators Market Sales By Geography (USD MN)
• Weight Loss Stabilizers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital Stores Market Sales By Geography (USD MN)
• Retail Pharmacy Stores Market Sales By Geography (USD MN)
• Online Pharmacies Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.